Advanced 2D imaging and analysis help scientists rapidly trace anatomical and molecular aspects of diseases to advance drug discovery

As the industry grows, so does the increased need for potency testing.

Acquisition will expand BioIVT’s ADME-Toxicology product line

Offers greater accuracy and comprehensive target identification in all human cell types

Researchers hope that by precisely modulating how our immune system responds to infection, they can develop new therapies that can be used to treat people with these serious diseases

D360 Partner™ provides secure data access and facilitates collaboration on drug discovery projects between pharmaceutical research teams at multiple organizations

The transformative impact of calorimetry-focused 3D phenotype assays—strengthening diagnostics in drug discovery and personalized medicine

Notable private equity firm invests £2.5 million in the Cambridge-based biotech

New method quickly, economically, and accurately tracks multiple in vivo interactions

Image and data management platform marks a major upgrade for both pharma and academic researchers